Androgen and Estrogen Receptor Co-Expression Determines the Efficacy of Hormone Receptor-Mediated Radiosensitisation in Breast Cancer

Scientists assessed radiosensitisation of androgen receptor (AR)-positive, estrogen receptor (ER)-positive cell lines using pharmacologic or genetic inhibition/degradation of AR and/or ER.